Search research articles

Search research articles

Related Experiment Videos

Preemptive public policy for genomics.

Rick J Carlson¹

¹University of Washington, Seattle, WA, USA.

Journal of Health Politics, Policy and Law

|February 7, 2008

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications.

Drug metabolism reviews·2008

Same author

The case of BiDil: a policy commentary on race and genetics.

Health affairs (Project Hope)·2005

Same author

Ready for genomic medicine? Perspectives of health care decision makers.

Archives of internal medicine·2005

Same journal

Still Learning from Oregonians About Medicaid.

Journal of health politics, policy and law·2026

Same journal

Communicative Infrastructure and the Global Diffusion of Latin American Food Policy.

Journal of health politics, policy and law·2026

Same journal

Frankenstein or My Fair Lady? Lessons on Participatory Governance from Oregon Medicaid's Priority-Setting Experiment.

Journal of health politics, policy and law·2026

Same journal

How Medicare Advantage Enrollment Affects Spending in Traditional Medicare: Spillovers and Implications for MA Benchmarks.

Journal of health politics, policy and law·2026

Same journal

Abortion Politics: Physician Mobilization in the Wake of the Dobbs Decision.

Journal of health politics, policy and law·2026

Same journal

When Protections Work but Processes Stall: Evaluating the No Surprises Act's Implementation Record.

Journal of health politics, policy and law·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Genomics offers profound scientific insights into life and health, enabling cost-effective primary prevention in healthcare. Vigorous public debate and policy leadership are crucial for wise integration of this evolving knowledge.

Area of Science:

Genomics and its application in understanding biological development and health.
Biotechnology and its intersection with genomic science.

Background:

Genomics is often perceived as solely a tool for biotechnology, a view considered shallow and short-sighted.
Genomic science provides fundamental knowledge about life processes, health, and future implications.
Genomic technologies present disruptive but potentially cost-effective solutions in healthcare, particularly for primary prevention.

Purpose of the Study:

To highlight the scientific depth of genomics beyond its technological applications.
To emphasize the role of genomics in enabling primary prevention and managing healthcare costs.
To underscore the need for public discourse and policy development regarding genomics.

Main Methods:

The abstract does not detail specific experimental methods.

Related Experiment Videos

It relies on conceptual analysis and argumentation regarding the implications of genomics.

Main Results:

Genomics is presented as a powerful scientific discipline with significant healthcare potential.
Genomic technologies can be cost-effective by enabling primary prevention.
Significant challenges and alarming bioethical and social-policy implications exist.

Conclusions:

Genomics is a profound science with transformative potential for health and society.
Effective integration requires addressing significant bioethical and social-policy challenges.
Vigorous public debate and proactive public policy are essential for wise implementation of genomics.